
Investigators at Memorial Sloan Kettering Cancer Center determined valganciclovir was the preferred first-line preemptive therapy to prevent cytomegalovirus in patients following an allogeneic hematopoietic cell transplantation.
Investigators at Memorial Sloan Kettering Cancer Center determined valganciclovir was the preferred first-line preemptive therapy to prevent cytomegalovirus in patients following an allogeneic hematopoietic cell transplantation.
The length of mechanical friction applied to the needleless connector of a central venous catheter before insertion may make a difference in rate of disinfection.
A study conducted at the Salvador Zubirán National Institute of Health Sciences and Nutrition found that there were no cases of active tuberculosis detected in HSCT patients.
Investigators detected no relevant change in systemic concentrations of 9 probe drugs when rezafungin was dosed concomitantly.